CJC-1295 (No DAC) Product Brief

1. Compound Overview

CJC-1295 (No DAC), also referred to as Modified GRF 1-29, is a synthetic analog of growth hormone releasing hormone (GHRH).
Unlike CJC-1295 with DAC, the no-DAC version has a shorter half-life and is designed to mimic the body’s natural pulsatile growth hormone release patterns.

It is commonly studied in research exploring growth hormone signaling, metabolism, recovery pathways, and body composition regulation.

2. Mechanism of Interest

CJC-1295 (No DAC) is studied for several biological mechanisms:

• Activation of the GHRH receptor
  • Stimulation of endogenous growth hormone release
  • Support of pulsatile GH secretion patterns
  • Potential increase in IGF-1 signaling pathways
  • Influence on metabolic and recovery-related pathways

3. Research Areas Being Explored

• Growth hormone pulsation research
  • Body composition studies
  • Recovery and regeneration pathways
  • Sleep quality research models
  • Metabolic signaling studies

4. Safety and Regulatory Notes

CJC-1295 (No DAC) is not approved by the FDA for medical treatment and is commonly distributed as a research compound.

This document is intended for informational and research product description purposes only.